HRMY

Market-moving news on Harmony Biosciences (NASDAQ: HRMY): filings, earnings, deals and other events, from REDFILED.

HRMY

A Harmony Biosciences insider exercised 38,452 options at $30.27 and $30.69 and sold the same number of shares at about $43 over three days.

HRMY

The registry entry for Harmony's Phase 3 study of cannabidiol in Fragile X syndrome now shows a status of COMPLETED, updated 1 September 2026.